During this briefing, panelists will explain the mechanisms of biologic drugs, explore the impact of current regulations on the uptake of biosimilars, and discuss considerations for the biosimilars market in the United States.
The on-the-record, reporter-only briefing will begin with remarks from Rep. DeGette, followed by a moderated question and answer session.
During this summit, panelists explored how we can reframe the conversation around aging in America and discussed opportunities to improve health outcomes for older adults. Speakers discussed innovative payment models and approaches to integrating non-medical needs into those models as well as upcoming policy and regulatory priorities.
The panelists discussed the recent ruling made by the United States District Court for the Northern District of Texas on the Affordable Care Act.
The Program Assistant will be a critical part of the Alliance policy team. Our ability to accomplish our mission to foster health policy knowledge, understanding, and dialogue depends upon the consistent production of high-quality and unbiased programming for our core audience, including members of Congress, congressional and executive branch staff, media, and health policy stakeholders. The Program Assistant will ensure our logistical planning processes run smoothly and will convey a polished, professional image to our speakers and event attendees.
The Alliance for Health Policy seeks a highly motivated and energetic individual for the position of events and outreach assistant who is looking to gain insight into the internal operations and business development of a not-for-profit organization. This position has a key role in fundraising and development as well as events coordination and planning for the organization. The events and outreach assistant will support the management of strategic relationships for the organization and provide administrative support for the President and CEO.
This briefing is the last event in our 2018 Signature Series and we will explore the unique health and social needs of older adults and how to develop age-friendly communities that give aging Americans convenient access to all of the services they need.
The audience will come away with a better understanding of the origins of the rebate system, the actors responsible for negotiation, and the impact of rebates on prescription drug prices.
This webinar examined the role of health care in the upcoming elections and the potential health policy implications for Congress, the administration, and state governments.
During this on-the-record briefing for reporters, Anna Greenberg, managing partner at Greenberg Quinlan Rosner Research, and Dan Judy, research analyst for North Star Opinion Research, will discuss how public opinion on health care has informed campaign platforms and impacted voter attitudes.
This webinar examined the landscape of impending health policy legal decisions, including constitutional challenges to the ACA, disputes surrounding risk corridor programs, challenges to Medicaid program work requirements, and disputes around Medicaid expansion ballot initiatives.
Joe Grogan, J.D., associate director of Health Programs at the Office of Management and Budget will speak at the reporter breakfast on Thursday, September 20, 2018. This event is for reporters only.
During this briefing, panelists described factors that impact the quality, affordability, and accessibility of care for children with complex medical needs.
This briefing informed policymakers and the public on the drivers and impacts of declining life expectancy in the U.S. as well as highlighted the development of state and federal policy solutions to address these trends.
This congressional briefing explored the differences between “price” and “cost” in our current system and the potential policy options that address these discrepancies.
During this off-the-record briefing, congressional staff will have the opportunity to openly discuss policies and engage with experts on the status of the individual health insurance market.
This briefing discussed the current landscape of the individual health insurance market as well as state responses to stabilize their markets.
The conversation on health care costs in America is decades old, yet progress has been elusive. Terms like sustainability, affordability, and value are set forward as goals, but perspectives on how to achieve them vary widely. Speakers and panelists will provide insights on current and projected health care cost trends, what different stakeholders hope to achieve, and new approaches to consider.
This exclusive reporter briefing featured FDA Commissioner Scott Gottlieb, M.D., followed by a panel of industry leaders and stakeholders responding to new drug pricing guidance.